ng-nitroarginine methyl ester and Cirrhosis

ng-nitroarginine methyl ester has been researched along with Cirrhosis in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (14.47)	18.2507
2000's	34 (44.74)	29.6817
2010's	28 (36.84)	24.3611
2020's	3 (3.95)	2.80

Authors

Authors	Studies
André, H; Arroyo-Barrios, A; Mate, A; Reyes-Goya, C; Santana-Garrido, Á; Vázquez, CM	1
Fares, N; Ismail, A; Saliba, Y	1
Balkan, W; Cai, R; Dulce, RA; Hare, JM; Kanashiro-Takeuchi, RM; Kazmierczak, K; Schally, AV; Sha, W; Takeuchi, LM	1
Berg, G; Bertera, FM; Carranza, A; Chiappetta, DA; Del Mauro, JS; Donato, M; Fernandez Machulsky, N; Gelpi, RJ; González, GE; Gorzalczany, SB; Höcht, C; Morales, C; Morettón, MA; Prince, PD; Taira, CA	1
Cuello-Carrión, FD; Docherty, N; Manucha, W; Mazzei, L	1
Adamcova, M; Aziriova, S; Balazova, L; Celec, P; Krajcirovicova, K; Pechanova, O; Repova, K; Simko, F; Tothova, L; Vrankova, S; Zorad, S	1
Ding, Z; Jiang, S; Li, C; Li, J; Liu, L; Liu, Y; Xie, J; Zhang, X; Zhang, Y; Zhu, W	1
Bachelier, K; Böhm, M; Hall, R; Jagoda, P; Kazakov, A; Lammert, F; Laufs, U; Müller-Best, P; Semenov, A	1
Arévalo, M; Blanca, AJ; Mate, A; Miguel-Carrasco, JL; Ruiz-Armenta, MV; Vázquez, CM; Zambrano, S	1
Jia, Z; Li, J; Liu, J; Qi, Z; Tang, X; Tian, W; Wu, P; Yang, L; Zhang, J; Zhu, M	1
Coelho-Filho, OR; Jerosch-Herold, M; Kwong, R; Mitchell, R; Moreno, H; Neilan, TG; Shah, RV	1
Araki, S; Hanatani, S; Izumiya, Y; Kimura, Y; Ogawa, H; Rokutanda, T; Walsh, K	1
Chibbar, R; Ndisang, JF	1
Li, J; Liu, J; Lu, P; Qi, Z; Ren, J; Tian, W; Yang, L; Zhu, M	1
Hirai, M; Inden, Y; Murohara, T; Shimano, M; Takefuji, M; Tsuji, Y; Yamamoto, T; Yanagisawa, S; Yoshida, N	1
Bunbupha, S; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Prachaney, P; Welbat, JU	1
Biwer, LA; D'Souza, KM; Hale, TM; Madhavpeddi, L; Ramaiah, P; Shahid, W	1
Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA	1
Chatterjee, S; Manivannan, J; Raja, B; Silambarasan, T	1
Cheon, SA; Chung, JF; Joo, MY; Kim, B; Kim, KH; Lee, SJ; Park, SH; Park, TJ; Seo, ES; Sood, AK; Yang, JS; Yoon, CJ	1
Cho, JY; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Piao, ZH; Ryu, Y; Sun, S	1
Akita, Y; Iwasaka, T; Matsuhisa, S; Moriguchi, A; Okazaki, T; Otani, H; Sato, D; Yamashita, K	1
Hayashida, H; Hirakata, H; Iida, M; Ikeda, H; Masutani, K; Toyonaga, J; Tsuruya, K	1
Braun-Dullaeus, RC; Ebner, B; Forkmann, M; Heerwagen, C; Kasper, M; Marquetant, R; Schmeisser, A; Schober, K; Schoen, S; Strasser, RH; Wunderlich, C	1
Akashiba, A; Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y	1
Adamcova, M; Barta, A; Krajcirovicova, K; Paulis, L; Pechanova, O; Pelouch, V; Simko, F; Zicha, J	1
Berger, S; Duan, SZ; Frieler, RA; Ivaschenko, CY; Lumeng, CN; Mortensen, RM; Schütz, G; Usher, MG	1
Bigé, N; Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Jouanneau, C; Mihout, F; Ronco, P; Shweke, N	1
Combe, C; Delmas, Y; Deminière, C; Derieppe, M; Gennisson, JL; Grenier, N; Placier, S; Tanter, M	1
Fujita, M; Iwasaka, T; Okazaki, T; Otani, H; Shimazu, T; Yoshioka, K	1
Babál, P; Hlavačková, L; Janega, P; Pecháňová, O; Vranková, S	1
Burns, KD; deBlois, D; Hale, TM; Robertson, SJ	1
Li, X; Liu, C; Sun, D; Wang, Y; Xiao, A; Zhou, X	1
Bienvenu, LA; Cranston, GA; Delbridge, LM; Fletcher, EK; Morgan, J; Rickard, AJ; Tesch, GH; Young, MJ	1
Dinda, AK; Maulik, SK; Prabhakar, P; Seth, S	1
Arévalo, M; Blanca, AJ; Mate, A; Miguel-Carrasco, JL; Ruiz-Armenta, MV; Vázquez, CM; Vázquez, MJ; Zambrano, S	1
Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Fakhouri, F; Flamant, M; Tharaux, PL	1
Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Lu, Y; Placier, S; Stefanski, A	1
Arroyo, V; Cejudo-Martín, P; Fernández-Varo, G; Jiménez, W; Morales-Ruiz, M; Rivera, F; Rodés, J; Ros, J; Solé, M	1
Chiba, Y; Fujiwara, Y; Hasegawa, H; Kibira, S; Miura, H; Miura, M; Saito, T; Terata, Y; Watanabe, H	1
Daig, U; Krämer, S; Liefeldt, L; Martini, S; Neumayer, HH; Peters, H; Rückert, M; Schäper, F	1
Boffa, JJ; Chansel, D; Chatziantoniou, C; Dussaule, JC; Flamant, M; Vandermeersch, S; Ying, L	1
Duggan, KA; Hodge, G; Ye, VZ; Yong, JL	1
Babal, P; Gvozdjakova, A; Krajcirovicova, K; Kucharska, J; Luptak, I; Matuskova, J; Pechanova, O; Simko, F	1
Chansel, D; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Placier, S; Tharaux, PL	1
Gröne, HJ; Gross, V; Janke, J; Kiss, E; Langenickel, TH; Luft, FC; Mazak, I; Müller, DN; Obst, M; Shagdarsuren, E	1
Catanzaro, DF; Chen, R; Hu, L; Laragh, JH; Merali, C; Sealey, JE; Shi, Y; Zhou, Y	1
Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H	1
Abe, Y; Date, T; Mochizuki, S; Nagai, M; Okada, T; Seki, S; Tanaka, Y; Taniguchi, I; Taniguchi, M	1
Xavier-Vidal, R	1
Chen, J; El Chaar, M; Felsen, D; Gallagher, R; Ito, K; Khodadadian, JJ; Poppas, DP; Seshan, SV; Vaughan, ED	1
Kim, HH; Liao, JK; Noma, K; Oyama, N; Rikitake, Y; Satoh, M; Wang, CY	1
Antunes, E; Araujo, EG; De Nucci, G; Faro, R; Guaraldo, AM; Zanfolin, M	1
Asano, Y; Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Minamino, T; Okada, K; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H; Tsukamoto, O; Yamasaki, S; Yulin, L	1
Baba, Y; Fukuo, K; Higuchi, M; Kawamoto, H; Maeda, N; Ogihara, T; Ozaki, T; Rakugi, H; Yasuda, O; Yotsui, T	1
Adamcova, M; Hulin, I; Janega, P; Krajcirovicova, K; Matuskova, J; Paulis, L; Pechanova, O; Pelouch, V; Potacova, A; Simko, F; Simko, J	1
Hou, Y; Matsuo, O; Okada, K; Okamoto, C; Ueshima, S	1
Egashira, K; Kadokami, T; Numaguchi, K; Shimokawa, H; Sueishi, K; Takemoto, M; Takeshita, A	1
Campbell, SE; Sigusch, HH; Weber, KT	1
Ishidoya, S; Klahr, S; McCracken, R; Morrissey, JJ	1
Egashira, K; Numaguchi, K; Shimokawa, H; Sueishi, K; Takemoto, M; Takeshita, A; Tomita, H; Tsutsui, H; Usui, M	1
Nakamura, T	1
Andoh, TF; Bennett, WM; Gardner, MP	1
Egashira, K; Kitabatake, A; Okamoto, H; Shimokawa, H; Sueishi, K; Takemoto, M; Takeshita, A; Tomita, H; Usui, M	1
Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE	1
de Lima, RJ; Madi, K; Marques, NM; Paes, Lda S; Reis, Ade A; Xavier-Vidal, R	1
Frohlich, ED; Fujimori, T; Matsuoka, H; Ono, H; Ono, Y	1
Babál, P; Bernátová, I; Pechánová, O	1
Antunes, E; Cintra, KA; De Luca, IM; De Nucci, G; de Oliveira, CF; Teixeira, SA	1
Andoh, TF; Bennett, WM; Shihab, FS; Yi, H	1
Egashira, K; Kitamoto, S; Koyanagi, M; Ni, W; Shimokawa, H; Takeshita, A; Takeya, M; Yoshimura, T	1
Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Tharaux, PL	1
Fukuma, T; Hara, T; Hirata, K; Hirata, M; Kage, M; Zhang, M	1
Brown, NJ; Fogo, AB; Kaikita, K; Ma, L; Schoenhard, JA; Vaughan, DE	1
Antunes, E; de Azevedo, AP; De Luca, IM; De Nucci, G; De Oliveira, CF; Pacca, SR	1
Brown, NJ; Fogo, AB; Kaikita, K; Painter, CA; Ripley, RT; Schoenhard, JA; Vaughan, DE	1

Reviews

1 review(s) available for ng-nitroarginine methyl ester and Cirrhosis

Article	Year
[Vasoactive peptides and the development of renal sclerosis: contribution of transgenes]. Journal de la Societe de biologie, 2002, Volume: 196, Issue:4 Topics: Angiotensin II; Animals; Collagen Type II; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Fibrosis; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Luciferases; MAP Kinase Signaling System; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta; Transgenes	2002

Article

Year

[Vasoactive peptides and the development of renal sclerosis: contribution of transgenes].

Journal de la Societe de biologie, 2002, Volume: 196, Issue:4

Topics: Angiotensin II; Animals; Collagen Type II; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Fibrosis; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Luciferases; MAP Kinase Signaling System; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta; Transgenes

2002

Other Studies

75 other study(ies) available for ng-nitroarginine methyl ester and Cirrhosis

Article	Year
Hypertension secondary to nitric oxide depletion produces oxidative imbalance and inflammatory/fibrotic outcomes in the cornea of C57BL/6 mice. Journal of physiology and biochemistry, 2022, Volume: 78, Issue:4 Topics: Animals; Biomarkers; Collagen; Cornea; Fibrosis; Hypertension; Mice; Mice, Inbred C57BL; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species	2022
Early Development of Cardiac Fibrosis in Young Old-Father Offspring. Oxidative medicine and cellular longevity, 2022, Volume: 2022 Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Blood Pressure; Fathers; Female; Fibrosis; Humans; Hypertension; Male; NG-Nitroarginine Methyl Ester; Rats; Transforming Growth Factor beta2	2022
Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction. American journal of physiology. Heart and circulatory physiology, 2023, 06-01, Volume: 324, Issue:6 Topics: Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Growth Hormone-Releasing Hormone; Heart Failure; Inflammation; Mice; NG-Nitroarginine Methyl Ester; Stroke Volume; Vascular Endothelial Growth Factor A; Ventricular Function, Left	2023
Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability. Journal of the American Society of Hypertension : JASH, 2017, Volume: 11, Issue:4 Topics: Amlodipine; Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Blood Pressure Determination; Carbazoles; Carvedilol; Collagen; Disease Models, Animal; Fibrosis; Heart Ventricles; Humans; Hypertension; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NG-Nitroarginine Methyl Ester; Propanolamines; Rats; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2017
Heat shock protein 70/nitric oxide effect on stretched tubular epithelial cells linked to WT-1 cytoprotection during neonatal obstructive nephropathy. International urology and nephrology, 2017, Volume: 49, Issue:10 Topics: Animals; Apoptosis; Arginine; Cells, Cultured; Cytoprotection; Epithelial Cells; Fibrosis; Gene Expression; HSP70 Heat-Shock Proteins; Kidney Cortex; Kidney Diseases; Kidney Tubules; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Rats; Rats, Inbred WKY; Stress, Mechanical; Ureteral Obstruction; WT1 Proteins	2017
Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril. International journal of molecular sciences, 2017, Jul-25, Volume: 18, Issue:8 Topics: Acetylcysteine; Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension; Light; Male; Melatonin; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Ventricular Remodeling	2017
HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism. Cardiovascular research, 2013, Sep-01, Volume: 99, Issue:4 Topics: Animals; Apoptosis; Fibrosis; Heart; HSP70 Heat-Shock Proteins; Humans; Mice; Mice, Transgenic; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-bcl-2; Vascular Endothelial Growth Factor A; Ventricular Remodeling	2013
Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis. Cardiovascular research, 2013, Nov-01, Volume: 100, Issue:2 Topics: Animals; Animals, Newborn; Blood Pressure; Cells, Cultured; Chemokine CXCL12; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Ventricular Function, Left	2013
L-carnitine attenuates the development of kidney fibrosis in hypertensive rats by upregulating PPAR-γ. American journal of hypertension, 2014, Volume: 27, Issue:3 Topics: Animals; Carnitine; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Hypertension; Inflammation Mediators; Interleukin-10; Interleukin-1beta; Interleukin-6; Kidney Diseases; Kidney Tubules, Proximal; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Wistar; Transforming Growth Factor beta1; Up-Regulation	2014
Exercise protects against chronic β-adrenergic remodeling of the heart by activation of endothelial nitric oxide synthase. PloS one, 2014, Volume: 9, Issue:5 Topics: Animals; Cardiomegaly; Fibrosis; Heart; Hemodynamics; Isoproterenol; Mice; Mice, Inbred C57BL; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Physical Conditioning, Animal; Proto-Oncogene Proteins c-akt; Receptors, Adrenergic, beta; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transcriptional Activation	2014
Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone. Journal of the American Heart Association, 2014, Jun-25, Volume: 3, Issue:3 Topics: Animals; Cardiac Imaging Techniques; Cardiomegaly; Fibrosis; Heart; Hypertension; Magnetic Resonance Imaging; Mice; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Receptors, Mineralocorticoid; Spironolactone; Stroke Volume	2014
Akt1-mediated fast/glycolytic skeletal muscle growth attenuates renal damage in experimental kidney disease. Journal of the American Society of Nephrology : JASN, 2014, Volume: 25, Issue:12 Topics: Adiponectin; Animals; Cytokines; Disease Models, Animal; Fibrosis; Glycolysis; Inflammation; Kidney; Mice; Mice, Transgenic; Muscle Proteins; Muscle, Skeletal; Muscles; Muscular Atrophy; Myofibroblasts; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Physical Conditioning, Animal; Proto-Oncogene Proteins c-akt; Renal Insufficiency; SKP Cullin F-Box Protein Ligases	2014
Heme Oxygenase Improves Renal Function by Potentiating Podocyte-Associated Proteins in Nω-Nitro-l-Arginine-Methyl Ester (l-NAME)-Induced Hypertension. American journal of hypertension, 2015, Volume: 28, Issue:7 Topics: Animals; Arginine; Biomarkers; Cytoprotection; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Extracellular Matrix Proteins; Fibrosis; Heme; Heme Oxygenase (Decyclizing); Hypertension; Inflammation Mediators; Kidney; Male; Mesoporphyrins; NG-Nitroarginine Methyl Ester; Oxidative Stress; Podocytes; Rats, Sprague-Dawley; Signal Transduction	2015
Nitric oxide synthase inhibition abolishes exercise-mediated protection against isoproterenol-induced cardiac hypertrophy in female mice. Cardiology, 2015, Volume: 130, Issue:3 Topics: Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Echocardiography; Enzyme Inhibitors; Female; Fibrosis; Isoproterenol; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phosphorylation; Physical Conditioning, Animal; Real-Time Polymerase Chain Reaction; Up-Regulation	2015
Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits. Heart rhythm, 2015, Volume: 12, Issue:6 Topics: Animals; Atrial Fibrillation; Blotting, Western; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Echocardiography; Electrophysiology; Endothelium; Enzyme-Linked Immunosorbent Assay; Fibrosis; Fluorescent Antibody Technique; Heart Atria; Heart Failure; Male; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphorylation; Piperidines; Rabbits; Tachycardia, Ventricular; Uracil	2015
Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension. Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:11 Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Collagen; Disease Models, Animal; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Pentacyclic Triterpenes; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha; Vascular Remodeling; Ventricular Remodeling	2015
Persistent change in cardiac fibroblast physiology after transient ACE inhibition. American journal of physiology. Heart and circulatory physiology, 2015, Volume: 309, Issue:8 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Collagen Type I; Disease Models, Animal; Enalapril; Fibroblasts; Fibrosis; Granulocyte-Macrophage Colony-Stimulating Factor; Heart Ventricles; Hypertension; Inflammation Mediators; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenotype; Rats, Inbred SHR; Time Factors	2015
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis. Journal of the American Heart Association, 2016, Jan-14, Volume: 5, Issue:1 Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2016
Prevention of cardiac dysfunction, kidney fibrosis and lipid metabolic alterations in l-NAME hypertensive rats by sinapic acid--Role of HMG-CoA reductase. European journal of pharmacology, 2016, Apr-15, Volume: 777 Topics: Acyl Coenzyme A; Animals; Antioxidants; Blood Pressure; Coumaric Acids; Fibrosis; Heart; Hypertension; Kidney; Lipid Peroxidation; Lipoproteins; Male; Mitochondria, Liver; Molecular Docking Simulation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Oxidative Stress; Protein Conformation; Rats; Rats, Wistar	2016
NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamil. Oncotarget, 2016, Jul-26, Volume: 7, Issue:30 Topics: Animals; Female; Fibrosis; Heptaminol; Hyperplasia; Killer Cells, Natural; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pindolol; Skin; Tetradecanoylphorbol Acetate; Tretinoin; Verapamil	2016
Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. Journal of hypertension, 2017, Volume: 35, Issue:7 Topics: Animals; Blood Pressure; Fibrosis; Gallic Acid; Heart Ventricles; Histone Deacetylase 1; Histone Deacetylase 2; Hypertension; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Ventricular Remodeling	2017
N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster. Antioxidants & redox signaling, 2008, Volume: 10, Issue:12 Topics: Acetylcysteine; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Benzylamines; Cardiomyopathies; Cricetinae; Drug Interactions; Enzyme Inhibitors; Fibrosis; Free Radical Scavengers; Heart; Heart Ventricles; Losartan; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organ Size; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Ventricular Function, Left; Ventricular Remodeling	2008
Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats. Kidney international, 2009, Volume: 75, Issue:2 Topics: Animals; Fibrosis; Hemodynamics; Inflammation; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Osteopontin; Protective Agents; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone	2009
Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice. Biochemical and biophysical research communications, 2008, Dec-19, Volume: 377, Issue:3 Topics: Animals; Cardiomyopathies; Caveolin 1; Enzyme Inhibitors; Fibrosis; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Physical Conditioning, Animal; Superoxides	2008
Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats. Journal of cardiology, 2008, Volume: 52, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Caspase 3; Fibrosis; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; RNA; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan; Ventricular Remodeling	2008
Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2009, Volume: 27, Issue:6 Topics: Animals; Blood Pressure; Fibrosis; Free Radical Scavengers; Heart Ventricles; Hemodynamics; Hydroxyproline; Hypertrophy; Male; Melatonin; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Wistar	2009
Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. The Journal of clinical investigation, 2010, Volume: 120, Issue:9 Topics: Aldosterone; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Fibrosis; Heart; Hypertension; Hypertrophy; Interleukin-4; Macrophages; Mice; Mice, Knockout; Mice, Transgenic; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Receptors, Glucocorticoid; Receptors, Mineralocorticoid	2010
Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis. The Journal of pathology, 2011, Volume: 223, Issue:1 Topics: Animals; Arginine; Collagen; Endothelin-1; Enzyme Inhibitors; Fibrosis; Gene Expression Regulation; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Renal Insufficiency, Chronic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta1	2011
Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats. European radiology, 2012, Volume: 22, Issue:1 Topics: Animals; Disease Models, Animal; Elasticity; Elasticity Imaging Techniques; Fibrosis; Glomerulosclerosis, Focal Segmental; Image Processing, Computer-Assisted; Kidney; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley	2012
Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:5 Topics: Administration, Oral; Angiogenesis Inducing Agents; Animals; Biopterins; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; GTP Cyclohydrolase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pterins; Recovery of Function; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Ventricular Function, Left	2011
The effect of indapamide on development of myocardial hypertrophy and fibrosis in L-NAME-induced hypertension in rat. Physiological research, 2011, Volume: 60, Issue:6 Topics: Animals; Captopril; Collagen Type I; Collagen Type III; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar	2011
Short-term ACE inhibition confers long-term protection against target organ damage. Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cell Proliferation; Creatinine; Disease Models, Animal; Enalapril; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Urea	2012
Effects of nitric oxide on renal interstitial fibrosis in rats with unilateral ureteral obstruction. Life sciences, 2012, Jun-14, Volume: 90, Issue:23-24 Topics: Animals; Arginine; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ureteral Obstruction; Vascular Endothelial Growth Factor A	2012
Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis. Endocrinology, 2012, Volume: 153, Issue:7 Topics: Aldosterone; Angiotensin Amide; Animals; Fibrosis; Heart; Hypertension; Macrophages; Male; Mice; Mice, Knockout; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenotype; Receptors, Mineralocorticoid; Signal Transduction; Time Factors	2012
Genistein prevents isoproterenol-induced cardiac hypertrophy in rats. Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:8 Topics: Animals; Cardiomegaly; Cardiotonic Agents; Catalase; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Genistein; Glutathione; Guanidines; Hydroxyproline; Isoproterenol; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances	2012
L-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-γ expression. Biochemical pharmacology, 2013, Apr-01, Volume: 85, Issue:7 Topics: Animals; Antihypertensive Agents; Carnitine; Collagen Type I; Collagen Type II; Connective Tissue Growth Factor; Fibrosis; Hypertension; Male; Membrane Glycoproteins; Myocardium; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Wistar; Transforming Growth Factor beta1	2013
Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:5 Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Collagen; Enzyme Inhibitors; Fibrosis; Gene Expression; Glomerulosclerosis, Focal Segmental; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta	2003
Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. The American journal of pathology, 2003, Volume: 162, Issue:6 Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteries; Ascites; Blood Circulation; Endothelium, Vascular; Enzyme Inhibitors; Fibrosis; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Renal Artery; Tunica Media	2003
Pitavastatin inhibits upregulation of intermediate conductance calcium-activated potassium channels and coronary arteriolar remodeling induced by long-term blockade of nitric oxide synthesis. Pharmacology, 2003, Volume: 68, Issue:4 Topics: Animals; Arterioles; Blood Pressure; Coronary Vessels; Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Hybridization; Lipids; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels, Calcium-Activated; Quinolines; Rats; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation	2003
NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis. Kidney international, 2003, Volume: 64, Issue:2 Topics: Animals; Arginine; Blood Pressure; Body Weight; Enzyme Inhibitors; Fibronectins; Fibrosis; Gene Expression; Glomerulonephritis; Isoantibodies; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrites; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Vessels; Captopril; Cyclic GMP; Endothelin-1; Enzyme Inhibitors; Fibrosis; Hypertension, Renal; Kidney; Male; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Protease Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Sodium Chloride; Survival Rate; Thiazepines	2003
Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat. Acta physiologica Scandinavica, 2003, Volume: 179, Issue:4 Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosis; Heart; Male; Metabolic Clearance Rate; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Random Allocation; Rats; Rats, Inbred SHR; Rats, Wistar; Sodium, Dietary; Vasoactive Intestinal Peptide	2003
Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Life sciences, 2004, Jan-23, Volume: 74, Issue:10 Topics: Animals; Aorta; Blood Pressure; Body Weight; Coenzymes; DNA; Enzyme Inhibitors; Fibrosis; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Wistar; Simvastatin; Ubiquinone; Ventricular Remodeling	2004
Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:7 Topics: Animals; Capillaries; Collagen; Collagen Type I; Creatinine; Endothelin-1; ErbB Receptors; Fibrosis; Gefitinib; Gene Expression Regulation; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Hypertension; Ischemia; Kidney; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proteinuria; Quinazolines; Rats; Rats, Sprague-Dawley	2004
Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice. Journal of hypertension, 2004, Volume: 22, Issue:5 Topics: Animals; Blood Pressure; Enzyme Inhibitors; Fibrosis; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Mutant Strains; NG-Nitroarginine Methyl Ester; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Ventricular Function, Left	2004
Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape. American journal of hypertension, 2004, Volume: 17, Issue:5 Pt 1 Topics: Angiotensin II; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosis; Infusions, Intravenous; Kidney; Models, Cardiovascular; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proteinuria; Rats; Rats, Sprague-Dawley; Renin; Time Factors; Troponin T; Vasoconstrictor Agents	2004
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Circulation, 2004, Aug-10, Volume: 110, Issue:6 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprolol; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Enzyme Induction; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertrophy; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Pressure; Rats; RNA, Messenger; Transcription, Genetic; Vasodilator Agents	2004
Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:11 Topics: Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Bradykinin; Coronary Circulation; Echocardiography; Enzyme Inhibitors; Fibrosis; Hypertension, Renal; Hypertrophy, Left Ventricular; Male; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Ventricular Remodeling	2004
Oxytalan elastic and collagen fibers during the repair process in experimental nitric oxide inhibition. Clinics (Sao Paulo, Brazil), 2005, Volume: 60, Issue:2 Topics: Animals; Collagen; Enzyme Inhibitors; Extracellular Matrix Proteins; Fibrosis; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar	2005
Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney international, 2005, Volume: 68, Issue:2 Topics: Animals; Arginine; Cyclic GMP; Dietary Supplements; Enzyme Inhibitors; Fibroblasts; Fibrosis; Glomerular Filtration Rate; In Situ Nick-End Labeling; Kidney; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Organ Size; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction	2005
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation, 2005, Nov-08, Volume: 112, Issue:19 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Protein Serine-Threonine Kinases; Quaternary Ammonium Compounds; rho-Associated Kinases; Vascular Diseases	2005
Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats. Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:3 Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Fibrosis; Guanylate Cyclase; Heart Rate; Hypertension; Male; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrazoles; Pyridines; Rats; Rats, Wistar	2006
The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats. Cardiovascular drugs and therapy, 2006, Volume: 20, Issue:2 Topics: Actins; Aldosterone; Animals; Blotting, Western; Cytochrome P-450 CYP11B2; Drug Therapy, Combination; Eplerenone; Fibrosis; Heart Failure; Heart Ventricles; Hypertension; Immunohistochemistry; Male; Mineralocorticoid Receptor Antagonists; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Proliferating Cell Nuclear Antigen; Protein Precursors; Random Allocation; Rats; Rats, Inbred WKY; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
Tissue inhibitor of metalloproteinase-3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nomega-nitro-L-arginine methyl ester in mice. Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:6 Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Fibrosis; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Oxidative Stress; Tissue Inhibitor of Metalloproteinase-3	2007
Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone. Acta physiologica (Oxford, England), 2008, Volume: 194, Issue:1 Topics: Animals; Aorta; Arginine; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Models, Animal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Spironolactone	2008
Alpha2-antiplasmin is a critical regulator of angiotensin II-mediated vascular remodeling. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:7 Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Collagen Type I; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Eye Proteins; Fibrosis; Gelatinases; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nerve Growth Factors; NG-Nitroarginine Methyl Ester; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Serpins; Thoracic Arteries; Tumor Suppressor Protein p53	2008
Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:6 Pt 1 Topics: Animals; Arginine; Blood Pressure; Cardiomegaly; Coronary Circulation; Coronary Vessels; Data Interpretation, Statistical; Enzyme Inhibitors; Fibrosis; Heart; Heart Rate; Histological Techniques; Hydralazine; Hypertension; Male; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred WKY	1995
Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin. Cardiovascular research, 1996, Volume: 31, Issue:4 Topics: Angiotensin II; Animals; Arginine; Bradykinin; Bradykinin Receptor Antagonists; Collagen; Cyclooxygenase Inhibitors; Fibrosis; Indomethacin; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Rats; Rats, Sprague-Dawley	1996
Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:10 Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Collagen; Enalapril; Enzyme Inhibitors; Female; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Ureteral Obstruction	1996
Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. The Journal of clinical investigation, 1997, Jan-15, Volume: 99, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Enzyme Inhibitors; Fibrosis; Immunohistochemistry; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Tissue Distribution	1997
[Contribution of L-arginine-derived nitric oxide to the structural integrity of coronary artery and cardiac interstitium, and to the regulation of sympathetic nerve activity: assessment using a rat model produced by chronic nitric oxide inhibition]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1997, Volume: 72, Issue:5 Topics: Animals; Arginine; Catecholamines; Chronic Disease; Coronary Vessels; Disease Models, Animal; Fibrosis; Heart Rate; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Renin; Sympathetic Nervous System	1997
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation, 1997, Nov-15, Volume: 64, Issue:9 Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Fibrosis; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Diseases	1997
Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:6 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Cardiomegaly; Coronary Vessels; Fibrosis; Heart; Heart Rate; Imidazoles; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Olmesartan Medoxomil; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Thiazepines	1997
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney international, 1998, Volume: 53, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling	1998
[Experimental anatomo-pathologic study in the myocardium of animals with arterial hypertension caused via a nitric oxide synthesis blocker]. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1999, Volume: 18, Issue:4 Topics: Animals; Enzyme Inhibitors; Fibrosis; Heart Atria; Heart Ventricles; Hypertension; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Time Factors	1999
Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:4 Pt 1 Topics: Animals; Apoptosis; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Fibrosis; Hemodynamics; Hypertension; Male; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred SHR	1999
Structural alterations in the heart after long-term L-NAME and D-NAME treatment. General physiology and biophysics, 1999, Volume: 18 Suppl 1 Topics: Animals; Blood Pressure; Enzyme Inhibitors; Fibrosis; Heart; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Stereoisomerism	1999
Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor. European journal of pharmacology, 2000, Mar-10, Volume: 391, Issue:1-2 Topics: Animals; Blood Pressure; Body Weight; Brain; Cardiomegaly; Enzyme Inhibitors; Fibrosis; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Wistar	2000
Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney international, 2000, Volume: 58, Issue:3 Topics: Animals; Arginine; Arterioles; Biglycan; Blood Pressure; Blotting, Northern; Chronic Disease; Collagen; Cyclosporine; Enzyme Inhibitors; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Gene Expression; Glomerular Filtration Rate; Hyalin; Immunosuppressive Agents; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasminogen Activator Inhibitor 1; Proteoglycans; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta	2000
Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation, 2000, Oct-31, Volume: 102, Issue:18 Topics: Animals; Antibodies, Monoclonal; Blood Pressure; Cell Division; Chemokine CCL2; Chronic Disease; Collagen; Coronary Artery Disease; Dermis; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Inflammation; Male; Monocytes; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Recombinant Proteins; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling	2000
Regression of renal vascular fibrosis by endothelin receptor antagonism. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2 Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Collagen; Collagen Type I; Endothelin Receptor Antagonists; Endothelins; Fibrosis; Gene Expression Regulation; Hypertension, Renovascular; Kidney Glomerulus; Luciferases; Male; Mice; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Perfusion; Renal Artery; Staining and Labeling; Sulfonamides; Time Factors	2001
Effect of nitric oxide synthase inhibition on Schistosoma japonicum egg-induced granuloma formation in the mouse liver. Parasite immunology, 2001, Volume: 23, Issue:6 Topics: Animals; Enzyme Inhibitors; Female; Fibrosis; Granuloma; Interleukin-13; Interleukin-4; Liver Diseases; Lysine; Mice; Mice, Inbred CBA; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Schistosoma japonicum; Schistosomiasis japonica	2001
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation, 2001, Aug-14, Volume: 104, Issue:7 Topics: Animals; Blood Pressure; Body Weight; Collagen; Coronary Vessels; Enzyme Inhibitors; Fibrosis; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time	2001
Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:2 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Body Weight; Enzyme Inhibitors; Fibrosis; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Propranolol; Rats; Rats, Wistar; Time Factors	2002
Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. Journal of molecular and cellular cardiology, 2002, Volume: 34, Issue:6 Topics: Animals; Body Weight; Coronary Disease; Coronary Vessels; Enzyme Inhibitors; Fibrosis; Hemodynamics; Hypertension; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Plasminogen Activators; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta	2002